As of 2025-07-11, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (185.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.79 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -3978.2%.
The range of the Relative Valuation is (150.99) - (207.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.4x | 20.3x |
| Forward P/E multiples | 17.8x - 29.1x | 23.4x |
| Fair Price | (150.99) - (207.55) | (185.77) |
| Upside | -3252.2% - -4433.0% | -3978.2% |
| Date | P/E |
| 2025-07-10 | -0.56 |
| 2025-07-09 | -0.54 |
| 2025-07-08 | -0.53 |
| 2025-07-07 | -0.54 |
| 2025-07-03 | -0.54 |
| 2025-07-02 | -0.53 |
| 2025-07-01 | -0.52 |
| 2025-06-30 | -0.54 |
| 2025-06-27 | -0.52 |
| 2025-06-26 | -0.50 |
| 2025-06-25 | -0.48 |
| 2025-06-24 | -0.52 |
| 2025-06-23 | -0.50 |
| 2025-06-20 | -0.53 |
| 2025-06-18 | -0.53 |
| 2025-06-17 | -0.48 |
| 2025-06-16 | -0.51 |
| 2025-06-13 | -0.54 |
| 2025-06-12 | -0.56 |
| 2025-06-11 | -0.55 |
| 2025-06-10 | -0.55 |
| 2025-06-09 | -0.52 |
| 2025-06-06 | -0.52 |
| 2025-06-05 | -0.52 |
| 2025-06-04 | -0.50 |
| 2025-06-03 | -0.52 |
| 2025-06-02 | -0.51 |
| 2025-05-30 | -0.49 |
| 2025-05-29 | -0.49 |
| 2025-05-28 | -0.48 |
| 2025-05-27 | -0.45 |
| 2025-05-23 | -0.46 |
| 2025-05-22 | -0.47 |
| 2025-05-21 | -0.47 |
| 2025-05-20 | -0.48 |
| 2025-05-19 | -0.47 |
| 2025-05-16 | -0.48 |
| 2025-05-15 | -0.48 |
| 2025-05-14 | -0.49 |
| 2025-05-13 | -0.49 |
| 2025-05-12 | -0.50 |
| 2025-05-09 | -0.50 |
| 2025-05-08 | -0.49 |
| 2025-05-07 | -0.48 |
| 2025-05-06 | -0.49 |
| 2025-05-05 | -0.51 |
| 2025-05-02 | -0.53 |
| 2025-05-01 | -0.52 |
| 2025-04-30 | -0.52 |
| 2025-04-29 | -0.52 |